Clinical Research
Copyright ©The Author(s) 2003.
World J Gastroenterol. Nov 15, 2003; 9(11): 2565-2569
Published online Nov 15, 2003. doi: 10.3748/wjg.v9.i11.2565
Table 7 Comparison of oxidation and anti-oxidation between treatment and control groups before and after therapy
Treatment group (n = 40)
Control group (n = 44)
Before therapyAfter therapyBefore therapyAfter therapy
P-VC (μmol/L)41.54 ± 2.9153.25 ± 10.11a41.78 ± 1.9645.21 ± 9.251)
P-VE (μmol/L)18.47 ± 3.4519.97 ± 4.26b18.67 ± 2.1319.24 ± 2.462)
P-LPO (μmol/L)13.53 ± 2.1211.54 ± 1.45a13.68 ± 2.3112.98 ± 2.751)
P-β-CAR (μmol/L)1.25 ± 0.171.37 ± 0.71b1.28 ± 0.211.34 ± 0.652)
WB-GSH (mmol/L)0.97 ± 0.181.39 ± 0.41a0.98 ± 0.211.04 ± 0.351)
E-SOD (U/g*Hb)1749.01 ± 50.551997.42 ± 145.331)1726.28 ± 71.371807.22 ± 120.211)
E-CAT (K/g*Hb)217.34 ± 19.51269.52 ± 65.321)220.18 ± 20.14239.17 ± 70.151)